GeneDx Holdings (WGS) Operating Margin (2020 - 2026)
GeneDx Holdings' (WGS) quarterly Operating Margin came in at 15.25% in Q2 2026, down 2398.0% year-over-year from 0.66% in Q2 2025, and up 72.86% quarter-over-quarter from 56.2% in Q1 2026.
Powered by 
Analysis
GeneDx Holdings (WGS) Operating Margin (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Operating Margin for 7 consecutive years, with 15.25% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Margin fell 2398.0% year-over-year to 15.25% in Q2 2026; TTM through Jun 2026 was 20.34%, a 2184.0% decrease from a year earlier, with the FY2025 full-year figure at 3.06%, up 454.0% from the prior year.
- Operating Margin was 15.25% for Q2 2026 at GeneDx Holdings, up from 56.2% in the prior quarter.
- Over five years, Operating Margin peaked at 9.21% in Q4 2024 and troughed at 529.56% in Q4 2022.
- A 5-year average of 96.97% and a median of 33.27% in 2024 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin slumped 35302 bps in 2022 and jumped 48489 bps in 2023, its largest moves.
- Over 5 years, Operating Margin stood at 529.56% in 2022, then surged by 92 bps to 44.66% in 2023, then jumped by 121 bps to 9.21% in 2024, then sank by 228 bps to 11.77% in 2025, then fell by 30 bps to 15.25% in 2026.
- The last three Operating Margin figures came in at 15.25% (Q2 2026), 56.2% (Q1 2026), and 11.77% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -10.07% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 12.10% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 5.03% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -22.04% |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -15.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.25% |
| Mar 31, 2026 | -56.20% |
| Dec 31, 2025 | -11.77% |
| Sep 30, 2025 | -2.78% |
| Jun 30, 2025 | 8.73% |
| Mar 31, 2025 | -5.22% |
| Dec 31, 2024 | 9.21% |
| Sep 30, 2024 | -10.12% |
| Jun 30, 2024 | -15.00% |
| Mar 31, 2024 | -21.88% |
| Dec 31, 2023 | -44.66% |
| Sep 30, 2023 | -80.61% |
| Jun 30, 2023 | -105.99% |
| Mar 31, 2023 | -139.93% |
| Dec 31, 2022 | -529.56% |
| Sep 30, 2022 | -109.11% |
| Jun 30, 2022 | -449.69% |
| Mar 31, 2022 | -165.56% |
| Dec 31, 2021 | -200.31% |
| Sep 30, 2021 | -204.42% |